GILEAD SCIENCES, INC. (GILD) Free cash flow 2016–2025
GILEAD SCIENCES, INC. (GILD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$9.5BFY2025 · since FY2016: $16.3B → $9.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.5B | -8.2% |
| FY2024 | $10.3B | +38.9% |
| FY2023 | $7.4B | -11.1% |
| FY2022 | $8.3B | -22.8% |
| FY2021 | $10.8B | +43.7% |
| FY2020 | $7.5B | -9.6% |
| FY2019 | $8.3B | +11.3% |
| FY2018 | $7.5B | -33.9% |
| FY2017 | $11.3B | -30.6% |
| FY2016 | $16.3B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GILD financial trends
GILD RevenueGILD Net incomeGILD Net marginGILD Gross profitGILD Gross marginGILD Operating incomeGILD Operating marginGILD Operating cash flowGILD Capital expendituresGILD Return on equityGILD Stock buybacksGILD Dividends paidGILD Total assetsGILD Total liabilitiesGILD Shareholders’ equityGILD overview →